United States Cancer Janus Kinase Inhibitors Market Report 2017

United States Cancer Janus Kinase Inhibitors Market Report 2017

1 Cancer Janus Kinase Inhibitors Overview

1.1 Product Overview and Scope of Cancer Janus Kinase Inhibitors

1.2 Classification of Cancer Janus Kinase Inhibitors by Product Category

1.2.1 United States Cancer Janus Kinase Inhibitors Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Cancer Janus Kinase Inhibitors Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Ruxolitinib

1.2.4 Momelotinib

1.2.5 Lestaurtinib

1.2.6 Pacritinib

1.2.7 Others

1.3 United States Cancer Janus Kinase Inhibitors Market by Application/End Users

1.3.1 United States Cancer Janus Kinase Inhibitors Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Breast Cancer

1.3.3 Pancreatic Cancer

1.3.4 Hepatocellular Carcinoma

1.3.5 Others

1.4 United States Cancer Janus Kinase Inhibitors Market by Region

1.4.1 United States Cancer Janus Kinase Inhibitors Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Cancer Janus Kinase Inhibitors Status and Prospect (2012-2022)

1.4.3 Southwest Cancer Janus Kinase Inhibitors Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Cancer Janus Kinase Inhibitors Status and Prospect (2012-2022)

1.4.5 New England Cancer Janus Kinase Inhibitors Status and Prospect (2012-2022)

1.4.6 The South Cancer Janus Kinase Inhibitors Status and Prospect (2012-2022)

1.4.7 The Midwest Cancer Janus Kinase Inhibitors Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Cancer Janus Kinase Inhibitors (2012-2022)

1.5.1 United States Cancer Janus Kinase Inhibitors Sales and Growth Rate (2012-2022)

1.5.2 United States Cancer Janus Kinase Inhibitors Revenue and Growth Rate (2012-2022)

2 United States Cancer Janus Kinase Inhibitors Market Competition by Players/Suppliers

2.1 United States Cancer Janus Kinase Inhibitors Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Cancer Janus Kinase Inhibitors Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Cancer Janus Kinase Inhibitors Average Price by Players/Suppliers (2012-2017)

2.4 United States Cancer Janus Kinase Inhibitors Market Competitive Situation and Trends

2.4.1 United States Cancer Janus Kinase Inhibitors Market Concentration Rate

2.4.2 United States Cancer Janus Kinase Inhibitors Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Cancer Janus Kinase Inhibitors Manufacturing Base Distribution, Sales Area, Product Type

3 United States Cancer Janus Kinase Inhibitors Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Cancer Janus Kinase Inhibitors Sales and Market Share by Region (2012-2017)

3.2 United States Cancer Janus Kinase Inhibitors Revenue and Market Share by Region (2012-2017)

3.3 United States Cancer Janus Kinase Inhibitors Price by Region (2012-2017)

4 United States Cancer Janus Kinase Inhibitors Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Cancer Janus Kinase Inhibitors Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Cancer Janus Kinase Inhibitors Revenue and Market Share by Type (2012-2017)

4.3 United States Cancer Janus Kinase Inhibitors Price by Type (2012-2017)

4.4 United States Cancer Janus Kinase Inhibitors Sales Growth Rate by Type (2012-2017)

5 United States Cancer Janus Kinase Inhibitors Sales (Volume) by Application (2012-2017)

5.1 United States Cancer Janus Kinase Inhibitors Sales and Market Share by Application (2012-2017)

5.2 United States Cancer Janus Kinase Inhibitors Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Cancer Janus Kinase Inhibitors Players/Suppliers Profiles and Sales Data

6.1 Astra Zeneca

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Cancer Janus Kinase Inhibitors Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Astra Zeneca Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Celon Pharmaceuticals

6.2.2 Cancer Janus Kinase Inhibitors Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Celon Pharmaceuticals Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Dynamic Pharma

6.3.2 Cancer Janus Kinase Inhibitors Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Dynamic Pharma Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Eli Lilly

6.4.2 Cancer Janus Kinase Inhibitors Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Eli Lilly Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Gilead Sciences

6.5.2 Cancer Janus Kinase Inhibitors Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Gilead Sciences Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Hanmi Pharmaceuticals

6.6.2 Cancer Janus Kinase Inhibitors Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Incyte

6.7.2 Cancer Janus Kinase Inhibitors Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Incyte Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Kyowa Hakko

6.8.2 Cancer Janus Kinase Inhibitors Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Kyowa Hakko Cancer Janus Kinase Inhibitors Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

7 Cancer Janus Kinase Inhibitors Manufacturing Cost Analysis

7.1 Cancer Janus Kinase Inhibitors Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Cancer Janus Kinase Inhibitors

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Cancer Janus Kinase Inhibitors Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Cancer Janus Kinase Inhibitors Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Cancer Janus Kinase Inhibitors Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Cancer Janus Kinase Inhibitors Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Cancer Janus Kinase Inhibitors Sales Volume Forecast by Type (2017-2022)

11.3 United States Cancer Janus Kinase Inhibitors Sales Volume Forecast by Application (2017-2022)

11.4 United States Cancer Janus Kinase Inhibitors Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

Figure Product Picture of Cancer Janus Kinase Inhibitors

Figure United States Cancer Janus Kinase Inhibitors Market Size (K Pcs) by Type (2012-2022)

Figure United States Cancer Janus Kinase Inhibitors Sales Volume Market Share by Type (Product Category) in 2016

Figure Ruxolitinib Product Picture

Figure Momelotinib Product Picture

Figure Lestaurtinib Product Picture

Figure Pacritinib Product Picture

Figure Others Product Picture

Figure United States Cancer Janus Kinase Inhibitors Market Size (K Pcs) by Application (2012-2022)

Figure United States Sales Market Share of Cancer Janus Kinase Inhibitors by Application in 2016

Figure Breast Cancer Examples

Table Key Downstream Customer in Breast Cancer

Figure Pancreatic Cancer Examples

Table Key Downstream Customer in Pancreatic Cancer

Figure Hepatocellular Carcinoma Examples

Table Key Downstream Customer in Hepatocellular Carcinoma

Figure Others Examples

Table Key Downstream Customer in Others

Figure United States Cancer Janus Kinase Inhibitors Market Size (Million USD) by Region (2012-2022)

Figure The West Cancer Janus Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Cancer Janus Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Cancer Janus Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Cancer Janus Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Cancer Janus Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Cancer Janus Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Cancer Janus Kinase Inhibitors Sales (K Pcs) and Growth Rate (2012-2022)

Figure United States Cancer Janus Kinase Inhibitors Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Cancer Janus Kinase Inhibitors Market Major Players Product Sales Volume (K Pcs) (2012-2017)

Table United States Cancer Janus Kinase Inhibitors Sales (K Pcs) of Key Players/Suppliers (2012-2017)

Table United States Cancer Janus Kinase Inhibitors Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Cancer Janus Kinase Inhibitors Sales Share by Players/Suppliers

Figure 2017 United States Cancer Janus Kinase Inhibitors Sales Share by Players/Suppliers

Figure United States Cancer Janus Kinase Inhibitors Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Cancer Janus Kinase Inhibitors Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Cancer Janus Kinase Inhibitors Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Cancer Janus Kinase Inhibitors Revenue Share by Players/Suppliers

Figure 2017 United States Cancer Janus Kinase Inhibitors Revenue Share by Players/Suppliers

Table United States Market Cancer Janus Kinase Inhibitors Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)

Figure United States Market Cancer Janus Kinase Inhibitors Average Price (USD/Pcs) of Key Players/Suppliers in 2016

Figure United States Cancer Janus Kinase Inhibitors Market Share of Top 3 Players/Suppliers

Figure United States Cancer Janus Kinase Inhibitors Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Cancer Janus Kinase Inhibitors Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Cancer Janus Kinase Inhibitors Product Category

Table United States Cancer Janus Kinase Inhibitors Sales (K Pcs) by Region (2012-2017)

Table United States Cancer Janus Kinase Inhibitors Sales Share by Region (2012-2017)

Figure United States Cancer Janus Kinase Inhibitors Sales Share by Region (2012-2017)

Figure United States Cancer Janus Kinase Inhibitors Sales Market Share by Region in 2016

Table United States Cancer Janus Kinase Inhibitors Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Cancer Janus Kinase Inhibitors Revenue Share by Region (2012-2017)

Figure United States Cancer Janus Kinase Inhibitors Revenue Market Share by Region (2012-2017)

Figure United States Cancer Janus Kinase Inhibitors Revenue Market Share by Region in 2016

Table United States Cancer Janus Kinase Inhibitors Price (USD/Pcs) by Region (2012-2017)

Table United States Cancer Janus Kinase Inhibitors Sales (K Pcs) by Type (2012-2017)

Table United States Cancer Janus Kinase Inhibitors Sales Share by Type (2012-2017)

Figure United States Cancer Janus Kinase Inhibitors Sales Share by Type (2012-2017)

Figure United States Cancer Janus Kinase Inhibitors Sales Market Share by Type in 2016

Table United States Cancer Janus Kinase Inhibitors Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Cancer Janus Kinase Inhibitors Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Cancer Janus Kinase Inhibitors by Type (2012-2017)

Figure Revenue Market Share of Cancer Janus Kinase Inhibitors by Type in 2016

Table United States Cancer Janus Kinase Inhibitors Price (USD/Pcs) by Types (2012-2017)

Figure United States Cancer Janus Kinase Inhibitors Sales Growth Rate by Type (2012-2017)

Table United States Cancer Janus Kinase Inhibitors Sales (K Pcs) by Application (2012-2017)

Table United States Cancer Janus Kinase Inhibitors Sales Market Share by Application (2012-2017)

Figure United States Cancer Janus Kinase Inhibitors Sales Market Share by Application (2012-2017)

Figure United States Cancer Janus Kinase Inhibitors Sales Market Share by Application in 2016

Table United States Cancer Janus Kinase Inhibitors Sales Growth Rate by Application (2012-2017)

Figure United States Cancer Janus Kinase Inhibitors Sales Growth Rate by Application (2012-2017)

Table Astra Zeneca Basic Information List

Table Astra Zeneca Cancer Janus Kinase Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Astra Zeneca Cancer Janus Kinase Inhibitors Sales Growth Rate (2012-2017)

Figure Astra Zeneca Cancer Janus Kinase Inhibitors Sales Market Share in United States (2012-2017)

Figure Astra Zeneca Cancer Janus Kinase Inhibitors Revenue Market Share in United States (2012-2017)

Table Celon Pharmaceuticals Basic Information List

Table Celon Pharmaceuticals Cancer Janus Kinase Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Celon Pharmaceuticals Cancer Janus Kinase Inhibitors Sales Growth Rate (2012-2017)

Figure Celon Pharmaceuticals Cancer Janus Kinase Inhibitors Sales Market Share in United States (2012-2017)

Figure Celon Pharmaceuticals Cancer Janus Kinase Inhibitors Revenue Market Share in United States (2012-2017)

Table Dynamic Pharma Basic Information List

Table Dynamic Pharma Cancer Janus Kinase Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Dynamic Pharma Cancer Janus Kinase Inhibitors Sales Growth Rate (2012-2017)

Figure Dynamic Pharma Cancer Janus Kinase Inhibitors Sales Market Share in United States (2012-2017)

Figure Dynamic Pharma Cancer Janus Kinase Inhibitors Revenue Market Share in United States (2012-2017)

Table Eli Lilly Basic Information List

Table Eli Lilly Cancer Janus Kinase Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Eli Lilly Cancer Janus Kinase Inhibitors Sales Growth Rate (2012-2017)

Figure Eli Lilly Cancer Janus Kinase Inhibitors Sales Market Share in United States (2012-2017)

Figure Eli Lilly Cancer Janus Kinase Inhibitors Revenue Market Share in United States (2012-2017)

Table Gilead Sciences Basic Information List

Table Gilead Sciences Cancer Janus Kinase Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Gilead Sciences Cancer Janus Kinase Inhibitors Sales Growth Rate (2012-2017)

Figure Gilead Sciences Cancer Janus Kinase Inhibitors Sales Market Share in United States (2012-2017)

Figure Gilead Sciences Cancer Janus Kinase Inhibitors Revenue Market Share in United States (2012-2017)

Table Hanmi Pharmaceuticals Basic Information List

Table Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitors Sales Growth Rate (2012-2017)

Figure Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitors Sales Market Share in United States (2012-2017)

Figure Hanmi Pharmaceuticals Cancer Janus Kinase Inhibitors Revenue Market Share in United States (2012-2017)

Table Incyte Basic Information List

Table Incyte Cancer Janus Kinase Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Incyte Cancer Janus Kinase Inhibitors Sales Growth Rate (2012-2017)

Figure Incyte Cancer Janus Kinase Inhibitors Sales Market Share in United States (2012-2017)

Figure Incyte Cancer Janus Kinase Inhibitors Revenue Market Share in United States (2012-2017)

Table Kyowa Hakko Basic Information List

Table Kyowa Hakko Cancer Janus Kinase Inhibitors Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)

Figure Kyowa Hakko Cancer Janus Kinase Inhibitors Sales Growth Rate (2012-2017)

Figure Kyowa Hakko Cancer Janus Kinase Inhibitors Sales Market Share in United States (2012-2017)

Figure Kyowa Hakko Cancer Janus Kinase Inhibitors Revenue Market Share in United States (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Cancer Janus Kinase Inhibitors

Figure Manufacturing Process Analysis of Cancer Janus Kinase Inhibitors

Figure Cancer Janus Kinase Inhibitors Industrial Chain Analysis

Table Raw Materials Sources of Cancer Janus Kinase Inhibitors Major Players/Suppliers in 2016

Table Major Buyers of Cancer Janus Kinase Inhibitors

Table Distributors/Traders List

Figure United States Cancer Janus Kinase Inhibitors Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)

Figure United States Cancer Janus Kinase Inhibitors Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Cancer Janus Kinase Inhibitors Price (USD/Pcs) Trend Forecast (2017-2022)

Table United States Cancer Janus Kinase Inhibitors Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Cancer Janus Kinase Inhibitors Sales Volume (K Pcs) Forecast by Type (2017-2022)

Figure United States Cancer Janus Kinase Inhibitors Sales Volume (K Pcs) Forecast by Type in 2022

Table United States Cancer Janus Kinase Inhibitors Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Cancer Janus Kinase Inhibitors Sales Volume (K Pcs) Forecast by Application (2017-2022)

Figure United States Cancer Janus Kinase Inhibitors Sales Volume (K Pcs) Forecast by Application in 2022

Table United States Cancer Janus Kinase Inhibitors Sales Volume (K Pcs) Forecast by Region (2017-2022)

Table United States Cancer Janus Kinase Inhibitors Sales Volume Share Forecast by Region (2017-2022)

Figure United States Cancer Janus Kinase Inhibitors Sales Volume Share Forecast by Region (2017-2022)

Figure United States Cancer Janus Kinase Inhibitors Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources